RichardZhu52/TestFiles2 · Datasets at Hugging Face

DrugBank ID stringlengths 7 7	Accession Numbers stringlengths 7 102 ⌀	Common name stringlengths 3 226	CAS stringlengths 7 12 ⌀	UNII stringlengths 10 10 ⌀	Synonyms stringlengths 2 1.48k ⌀	Standard InChI Key stringlengths 27 27 ⌀
DB19294	null	Japanese Encephalitis Virus Vaccine Inactivated	null	2V2JJ0S00T	JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED \| JE-VAX	null
DB19295	null	Platelet Rich Plasma	null	ZW1U5HYZ1A	AUTOLOGOUS CONDITIONED PLASMA \| AUTOLOGOUS PLATELET RICH PLASMA \| PLATELET RICH PLASMA HUMAN \| PLATELET-RICH PLASMA, AUTOLOGOUS \| PRP	null
DB19296	null	Linopristin	325965-23-9	312V80FR4J	Nxl-103 component rpr-202868	NVGNYGXBILPHOS-VXNAYKIUSA-N
DB19297	null	Human placenta hydrolysate	null	24L835P10X	Laennec	null
DB19298	null	7MW3711	null	null	null	null
DB19299	null	Interleukin-12 human recombinant	null	02FXP10O2U	Human interleukin 12 recombinant \| Human interleukin-12 recombinant \| Interleukin-12 human recombinant \| Recombinant human interleukin 12	null
DB19300	null	Crisugabalin	2209104-84-5	Q3MK7E8686	Crisugabalin	WCEFMBSFXJUREW-LIJGXYGRSA-N
DB19301	null	Solrikitug	2768721-24-8	WYT4WRY5YF	Immunoglobulin G1-kappa, anti-[Homo sapiens CRLF2 (cytokine receptor like factor 2,TSLP, thymic stromal lymphopoietin)], humanized monoclonal antibody \| Solrikitug	null
DB19302	null	Recaticimab	2361290-85-7	20IE6M67UX	Immunoglobulin g1-kappa, anti-(homo sapienspcsk9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, narc1, narc-1, proproteine convertase 9, pc9)), monoclonal antibody (recaticimab) \| Recaticimab	null
DB19303	null	Bemiltenase alfa	2766038-73-5	4EC84Z6PTT	null	null
DB19304	null	REM-422	null	null	c-Myb mRNA degrader REM-422 \| Myb mRNA degrader REM-422 \| Myb mRNA inhibitor REM-422	null
DB19305	null	JNT-517	2837993-05-0	5P44NDU6AC	(R)-3-(1-cyclopropyl-3-(2-fluoro-4-(trifluoromethoxy)benzyl)ureido)piperidine-1-carboxamide \| 1-Piperidinecarboxamide, 3-[cyclopropyl[[[[2-fluoro-4-(trifluoromethoxy)phenyl]methyl]amino]carbonyl]amino]-, (3R)-	FNRHWODWSBDOOY-CYBMUJFWSA-N
DB19306	null	XK-469 free acid	157435-10-4	A9M6WCT45L	PROPANOIC ACID, 2-(4-((7-CHLORO-2-QUINOXALINYL)OXY)PHENOXY)-, (±)- \| XK 469 free acid \| XK469 free acid	NUQZXROIVGBRGR-UHFFFAOYSA-N
DB19307	null	Human anti-il-6 monoclonal antibody (pf-04236921)	1822383-06-1	2NHW9AKY9C	HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY (PF-04236921)	null
DB19308	null	Coptisine	3486-66-6	0GCL71VN14	6,7-dihydrobis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium \| 7,8,13,13a-tetradehydro-2,3:9,10-bismethylenedioxyberbinium \| Alkaloid a, from coptis groenlandica \| Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)- \| Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro- \| Bis(methylenedioxy)protoberberine \| Coptisin	XYHOBCMEDLZUMP-UHFFFAOYSA-N
DB19309	null	IMM-0306	null	HFR7WU5YK7	IMM0306 (BISPECIFIC ANTIBODY-TRAP SELECTIVELY TARGETING CD47 AND CD20)	null
DB19310	null	Rhodamine 123 free base	104114-27-4	05D072FS97	Benzoic acid, 2-(6-amino-3-imino-3h-xanthen-9-yl)-, methyl ester	FCGVBHISQBBIQF-UHFFFAOYSA-N
DB19311	null	Farglitazar	274687-78-4	3433GY7132	L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)- \| N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE	ZZCHHVUQYRMYLW-HKBQPEDESA-N
DB19312	null	Sipoglitazar	342026-92-0	40O898CJZB	3-(3-ethoxy-1-(4-((2-phenyl-1,3-thiazol-4-yl)methoxy)benzyl)-1h-pyrazol-4-yl)propanoic acid	SRFCAWATPLCLMG-UHFFFAOYSA-N
DB19313	null	Salvianolic acid B	121521-90-2	C1GQ844199	(2s,3s)-4-((1e)-3-((1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propen-1-yl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylic acid 3-((1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl) ester \| Dan shen suan b \| Danfensuan b \| Lithospermic acid b \| Salvianolic acid b (constituent of chinese salvia)	SNKFFCBZYFGCQN-VWUOOIFGSA-N
DB19314	null	Nemonapride	75272-39-8	Q88T5P3444	(+/-)-cis-n-(1-benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide \| Benzamide, 5-chloro-2-methoxy-4-(methylamino)-n-(2-methyl-1- (phenylmethyl)-3-pyrrolidinyl)-, cis-(+/-)- \| Emilace \| Emonapride	KRVOJOCLBAAKSJ-RDTXWAMCSA-N
DB19315	null	Zelasudil	2365193-22-0	EEF2SY7GG2	Zelasudil	null
DB19316	null	Budoprutug	2720478-38-4	E4ET672BAP	Budoprutug	null
DB19317	null	KT-A261	null	null	null	null
DB19318	null	Pegtarazimod	2056232-82-5	7AUD376O4W	Pa-dpeg24 \| Pegtarazimod	null
DB19319	null	Enisoprost	81026-63-3	J85F4K48Q1	(+/-)-methyl (z)-7-((1r,2r,3r)-3-hydroxy-2-((e)-(4rs)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentyl)-4-heptenoate \| Enisoprost \| Prosta-4,13-dien-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (4z,11.alpha.,13e)-(+/-)-	CIBHDGPIOICRGX-ZQCHCGQNSA-N
DB19320	null	Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)	null	null	null	null
DB19321	null	Influenza A virus A/Sydney/1304/2022 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	null	null	null	null
DB19322	null	Influenza A virus A/Massachusetts/18/2022 (H3N2) recombinant hemagglutinin antigen	null	null	null	null
DB19323	null	Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (formaldehyde inactivated)	null	null	null	null
DB19324	null	Influenza A virus A/Thailand/8/2022 IVR-237 antigen (UV, formaldehyde inactivated)	null	null	null	null
DB19325	null	Sofpironium	1628251-49-9	00Y6A5AJU6	Pyrrolidinium, 3-(((2r)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy)-1-(2-ethoxy-2-oxoethyl)-1-methyl-, (3r)- \| Sofpironium cation \| Sofpironium ion	SEVCTUCCZYBJER-BSJAROSPSA-N
DB19326	null	Sabestomig	2648346-74-9	X79QP2R2CZ	Immunoglobulin G1 [239-phenylalanine,240-glutamic acid,336-serine,354-cysteine,371-serine,373-alanine,412-valine], bispecific, anti-(human programmed cell death protein 1) (human-Mus musculus clone LO115 γ1-chain) disulfide with human-Mus musculus clone \| Immunoglobulin G1-kappa/lambda, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD1, PD-1, CD279) and HAVCR2 (hepatitis A virus cellular receptor 2, T cell immunoglobulin and mucin domains family member 3, TIM3, TIM-3, TIMD3, CD366)], humanized and Ho	null
DB19327	null	Vilastobart	2760549-50-4	8FUE2D4G82	gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV1-6908 (84.7%) -(IGHD) -IGHJ401 (92.9%), CDR-IMGT[8.8.12] (26-33.51-58.97-108)) (1-119) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, D12, L14, G1v7 CH2 D3, E117 (CH1 K120 (216) (120-217), hinge 1- \| immunoglobulin G1-fused prodomain kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], humanized monoclonal antibody	null
DB19328	null	Bleximenib	2654081-35-1	DCN5WEN78T	Benzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)- \| N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamide	PDUGAXSIWNMIBQ-HHHXNRCGSA-N
DB19329	null	Azelaprag	2049980-18-7	4B8REJ8ZGY	2-pyrimidineethanesulfonamide, n-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-.alpha.,.beta.,5-trimethyl-, (.alpha.s,.beta.r)-	DOMQFIFVDIAOOT-ROUUACIJSA-N
DB19330	null	Tomligisiran	2202789-48-6	35S90A5FLO	RNA, ((1'-DE(6-AMINO-9H-PURIN-9-YL))DA-(5'->5')-CM-GM-CM-UM-GM-UM-AM-GM-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)A-UM-AM-AM-AM-UM-UM-GM-GM-UM-AM-(3'->3')-SP-(1'-DE(6-AMINO-9H-PURIN-9-YL))DA), 3'-(O-(CIS-4-((3S,8S)-17-((2-(ACETYLAMI	null
DB19331	null	Daplusiran	2202783-35-3	HP2ZTB8W0F	RNA, (AM-SP-(2'-DEOXY-2'-FLUORO)G-SP-AM-SP-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)A-UM-(2'-DEOXY-2'-FLUORO)U-GM-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)G-UM-(2'-DEOXY-2'-FLUORO)C-CM-AM-SP-CM),	null
DB19332	null	Zifibancimig	2517939-46-5	4UIR9KL62T	Immunoglobulin G1 Fab fragment, bispecific, anti-(human vascular endothelial growth factor A and angiopoietin 2) (human monoclonal RO7250284 γ1-chain), disulfide with human monoclonal RO7250284 κ-chain \| mmunoglobulin Fab G1-kappa, anti-[Homo sapiens ANGPT2 (angiopoietin 2, Ang2)] and anti-[Homo sapiens VEGFA (vascular endothelial growth factor A, VEGF-A, VEGF), monoclonal antibody, bispecific, biparatope monovalent	null
DB19333	null	Abiprubart	2765071-95-0	TIN30KQI3W	Gamma4 heavy chain humanized (1-441) [VH (Homo sapiens IGHV1-301 (83.7%) -(IGHD) -IGHJ401 (92.9%), CDR-IMGT [8.8.7] (26-33.51-58.97-103)) (1-114)-Homo sapiens IGHG4*01, nG4m(a) CH2 L92, G4v5 h P10 (CH1 (115-212), hinge 1-12 S10>P (222) (213-224), CH2 L \| Immunoglobulin G4 [222-proline], anti-(human CD40 antigen) (human-Mus musculus monoclonal KPL-404 γ4-chain), disulfide with human-Mus musculus monoclonal KPL-404 κ-chain, dimer \| Immunoglobulin G4-kappa, anti-[Homo sapiens CD40 (TNFRSF5, tumor necrosis factor receptor (TNFR) superfamily member 5, p50)], humanized monoclonal antibody	null
DB19334	null	Nelistotug	2645437-82-5	7MCC43O1YB	Gamma1 heavy chain Homo sapiens (1-452) [VH(Homo sapiens IGHV1-6901 (95.9%) -(IGHD)-IGHJ101 (90.9%) L123>T (117), CDR-IMGT [8.8.15](26-33.51-58.97-111)) (1-122) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (219) (123-220), hi \| Immunoglobulin G1, anti-(human CD96 antigen) (human monoclonal GSK6097608 γ1-chain), disulfide with human monoclonal GSK6097608 κ-chain, dimer \| Nelistotug (immunoglobulin G1-kappa, anti-[Homo sapiens CD96 (T cell activation increased late expression, TACTILE, T-cell surface protein tactile)], Homo sapiens monoclonal antibody)	null
DB19335	null	Peginterferon Alfacon-2	1848968-91-1	45EW5LFT2J	Interferon .alpha.1 (synthetic), n-terminal 20-kilodalton pegylated	null
DB19336	null	Zelquistinel	2151842-64-5	387WYR6N95	tert-butyl (4S)-2-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-3-oxo-2,5-diazaspiro[3.4]octane-5-carboxylate	ABAPCYNTEPGBNJ-FTGAXOIBSA-N
DB19337	null	Nesvategrast	1621332-91-9	49958O183Z	(s)-3-(6-(difluoromethoxy)pyridin-3-yl)-3-(oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoate \| 3-Pyridinepropanoic acid, 6-(difluoromethoxy)-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-, (βS)- \| βS)-6-(Difluoromethoxy)-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-3-pyridinepropanoic acid	IGUVQCZYMKVWFL-SFHVURJKSA-N
DB19338	null	Tebapivat	null	ORG4KGP5ZS	6-[(6-aminopyridin-2-yl)methyl]-4-methyl-2-[(1H-pyrazol-3-yl)methyl]-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one	DIUOELXIXSCFCR-UHFFFAOYSA-N
DB19339	null	Maridebart Cafraglutide	2760218-55-9	Z24U3U73HN	gamma1 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV3-3301 (92.9%) -(IGHD) -IGHJ401 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v64 CH2 C36, G1v54-30 CH2 C83, G8 \| Immunoglobulin G1, anti-(glucose-dependent insulinotropic polypeptide receptor) [275-cysteine,295-cysteine,300-glycine,305-cysteine] (human γ1-chain), disulfide with human κ-chain, dimer, 275,275′-bis(thioether) with 7-37-glucagon-like peptide I [8-(	null
DB19340	null	Tabirafusp tedromer	2412170-98-8	8ES4CE6CXN	1-[1,1,1-tris({3-[2-(2,2,2-tris{[(2-{α-(bromo / ethoxy / hydro / hydroxy)poly[1-(10,10-dimethyl-6-oxido-6-oxo-2,5,7-trioxa-10-aza-6λ5-phosphaundecan-10-ium-1-oyl)-1-methylethane-1,2-diyl]-ω-yl}-2-methylpropanoyl)oxy]methyl}ethoxy)acetamido]propanamido \| 3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6 \| Tedromer	GRHIAJGAQUTOSV-UHFFFAOYSA-N
DB19341	null	Englumafusp alfa	2417199-08-5	U4T9GD9GR9	71-248-4-1BB ligand (human precursor) fusion protein with peptide linker (GGGGS)2 fusion protein with 71-248-4-1BB ligand (human precursor) peptide linker (GGGGS)2 fusion protein with human κ-chain C region fusion protein with immunoglobulin G1 [497-ala \| Ensomafusp alfa \| humanized immunoglobulin G1-kappa anti-(human B-lymphocyte antigen CD19) modified heterodimer where the heavy and light chain variable regions of one arm have been substituted by three subunits of human 4- 1BB ligand (tumor necrosis factor ligand superfa	null
DB19342	null	Streptococcus pneumoniae type 9N capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	XI7GQF2NHD	null	null
DB19343	null	Streptococcus pneumoniae type 15A capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19344	null	Streptococcus pneumoniae type deOAc15B capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19345	null	Streptococcus pneumoniae type 16F capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19346	null	Streptococcus pneumoniae type 17F capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19347	null	Streptococcus pneumoniae type 20A capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19348	null	Streptococcus pneumoniae type 23A capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19349	null	Streptococcus pneumoniae type 23B capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19350	null	Streptococcus pneumoniae type 24F capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19351	null	Streptococcus pneumoniae type 31 capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19352	null	Streptococcus pneumoniae type 35B capsular polysaccharide diphtheria CRM197 protein conjugate antigen	null	null	null	null
DB19353	null	Benzgalantamine	224169-27-1	XOI2Q0ZF7G	6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, benzoate (ester), (4as,6r,8as)- \| Galantamine benzoate \| Memogain	JKVNJTYHRABHIY-WXVUKLJWSA-N
DB19354	null	Hydrastine	118-08-1	8890V3217X	(s)-6,7-dimethoxy-3-(r)-(6-methyl-5,6,7,8-tetrahydro-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)isobenzofuran-1(3h)-one \| Hydrastine (constituent of goldenseal) \| Phthalide (s)-6,7-dimethoxy-3-(r)-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-	JZUTXVTYJDCMDU-MOPGFXCFSA-N
DB19355	null	Chlorindanol	145-94-8	7902N03BH0	1h-inden-4-ol, 7-chloro-2,3-dihydro- \| 7-chloro-4-indanol \| Clorindanol	ATAJVFBUUIBIEO-UHFFFAOYSA-N
DB19356	null	Carboprost	35700-23-3	7B5032XT6O	(15s)-15-methyl-pgf2.alpha. \| (15s)-15-methylprostaglandin f(sub 2.alpha.) \| (15s)-15-methylprostaglandin f2.alpha. \| (5z,9.alpha.,11.alpha.,13e,15s)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid \| (e,z)-(1r,2r,3r,5s)-7-(3,5-dihydroxy-2-((3s)-(3-hydroxy-3-methyl-1-octenyl))cyclopentyl)-5-heptenoic acid \| 15-methyl-pgf2.alpha. \| 15-methylprostaglandin f2.alpha. \| 15-methylprostaglandin f2beta, (15s)- \| 15(S)-15-Methyl Prostaglandin F2α \| Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5z,9.alpha.,11.alpha.,13e,15s)-	DLJKPYFALUEJCK-IIELGFQLSA-N
DB19357	null	Salicin	138-52-3	4649620TBZ	2-(hydroxymethyl)phenyl-.beta.-d-glucopyranoside \| D-(-)-salicin \| D-salicin \| D(-)-salicin \| Salicinum \| Salicoside \| Salicyl alcohol glucoside	NGFMICBWJRZIBI-UJPOAAIJSA-N
DB19358	null	Chlorisondamine	7701-62-4	JD3M24F66I	1h-isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2- (trimethylammonio)ethyl)- \| Chlorisondamine cation \| Chlorisondamine ion \| Isoindolinium, 4,5,6,7-tetrachloro-2-methyl-2-(2- (trimethylammonio)ethyl)-	IXWDUZLHWJKVPX-UHFFFAOYSA-N
DB19359	null	Hydrastinine	6592-85-4	V1I0L48X6E	1-hydroxy-6,7-methylenedioxy-2-methyl-1,2,3,4-tetrahydroisoquinoline \| 1,3-dioxolo(4,5-g)isoquinolin-5-ol \| 5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-ol	YOJQZPVUNUQTDF-UHFFFAOYSA-N
DB19360	null	Latanoprost acid	41639-83-2	EJ85341990	13,14-dihydro-17-phenyl trinor pgf2.alpha. \| 13,14-dihydro-17-phenyl-18,19,20-trinor-pgf2.alpha. \| 5-heptenoic acid, 7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((3r)-3-hydroxy-5-phenylpentyl)cyclopentyl)-, (5z)- \| Latanoprost related compound e	HNPFPERDNWXAGS-NFVOFSAMSA-N
DB19361	null	Aurothioglycanide	16925-51-2	2A9D34A16M	.alpha.-auromercaptoacetanilide \| (((phenylcarbamoyl)methyl)thio)gold \| (2-mercapto-n-phenylacetamidato-o,s)gold \| 2-mercaptoacetanilide s-gold derivative \| Aurothioglycolanilide \| Aurothioglycolic acid anilide \| S-gold derivative of 2-mercaptoacetanilide	ODENGJOFMCVWCT-UHFFFAOYSA-M
DB19362	null	Glyceryl monocaprylate	26402-26-6	TM2TZD4G4A	Capmul 708g \| Capmul 808g \| Caprylin \| Cremercoor gc 8 \| Dermosoft gmcy \| Glyceryl caprylate \| Glyceryl monocaprylate type ii \| Glyceryl monooctanoate \| Glyceryl octanoate \| Imwitor 308 \| Lexgard gmcy \| Mgk glyceride \| Octanoic acid, monoester with glycerol \| Oristar gcc \| Sunsoft 700 p-2 \| Sunsoft 707	null
DB19363	null	Mephenesin carbamate	533-06-2	PAD6SXB23N	3-(2-methylphenoxy)-1,2-propanediol 1-carbamate	KRPAJLYSLFNDOA-UHFFFAOYSA-N
DB19364	null	Azaribine	2169-64-4	K1U80DO9EB	1,2,4-triazine-3,5(2h,4h)-dione, 2-(2,3,5-tri-o-acetyl-.beta.-d-ribofuranosyl)- \| 2-.beta.-d-ribofuranosyl-as-triazine-3,5(2h,4h)-dione 2',3',5'-triacetate \| 6-azauridine 2',3',5'-triacetate \| Triazure	QQOBRRFOVWGIMD-OJAKKHQRSA-N
DB19365	null	Aminometradine	642-44-4	PPM8SX5Q3V	1-allyl-6-amino-3-ethyluracil	NGXUUAFYUCOICP-UHFFFAOYSA-N
DB19367	null	Tiphenamil	82-99-5	GX4D5197DT	Benzeneethanethioic acid, .alpha.-phenyl-, s-(2-(diethylamino)ethyl) ester \| Benzeneethanethioic acid, a-phenyl-, s-(2-(diethylamino)ethyl) ester \| Thiphenamil \| Tifenamil	WHLUQAYNVOGZST-UHFFFAOYSA-N
DB19368	null	Amisometradine	550-28-7	30973N61ZF	2,4(1h,3h)-pyrimidinedione, 6-amino-3-methyl-1-(2-methyl-2-propenyl)- \| 6-amino-3-methyl-1-(2-methylallyl)-2,4(1h,3h)-pyrimidinedione	FXNYSZHYMGWWEZ-UHFFFAOYSA-N
DB19369	null	Mitomycin A	4055-39-4	87TMG6FJHV	6-methoxy analog of mitomycin c \| Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methyl-, (1as,8s,8ar,8bs)-	HYFMSAFINFJTFH-NGSRAFSJSA-N
DB19370	null	Methylhexaneamine	105-41-9	X49C572YQO	1,3-dimethylamylamine \| 2-amino-4-methylhexane \| 4-methyl-2-hexanamine \| Dimethylamylamine \| Floradrene \| Forthane \| Geranamine \| Methylhexanamine	YAHRDLICUYEDAU-UHFFFAOYSA-N
DB19371	null	NITHIAMIDE	140-40-9	9CBM60191Z	2-acetamido-5-nitrothiazole \| Acetamide, n-(5-nitro-2-thiazolyl)- \| Acinitrazole \| Aminitrozole \| N-(5-nitro-2-thiazolyl)acetamide	UJRRDDHEMZLWFI-UHFFFAOYSA-N
DB19372	null	Zoxazolamine	61-80-3	9DOW362Q29	2-amino-5-chlorobenzoxazole \| 5-chloro-2-benzoxazolamine \| Contrazole \| Deflexol \| Flexin \| Miazol \| Uri-boi \| Zoxamine \| Zoxine	YGCODSQDUUUKIV-UHFFFAOYSA-N
DB19373	null	Phenaglycodol	79-93-6	LMQ31KU50K	(+/-)-2-(p-chlorophenyl)-3-methyl-2,3-butanediol \| 2-(p-chlorophenyl)-3-methyl-2,3-butanediol \| 2,3-butanediol, 2-(4-chlorophenyl)-3-methyl- \| 2,3-butanediol, 2-(p-chlorophenyl)-3-methyl- \| Acalmid \| Alterton \| Felixyn \| Sinforil \| Stesil \| Ultran	HTYIXCKSEQQCJO-UHFFFAOYSA-N
DB19374	null	OCTODRINE	543-82-8	3GQ9E911BI	1,5-dimethylhexylamine \| 6-methyl-2-heptylamine \| Hexylamine, 1,5-dimethyl-	QNIVIMYXGGFTAK-UHFFFAOYSA-N
DB19375	null	Chlorothymol	89-68-9	LJ25TI0CVT	4-chlor-2-isopropyl-5-methylphenol \| 4-chloro-5-methyl-2-(1-methylethyl)phenol \| 4-chlorothymol \| 6-chlorothymol \| Phenol, 4-chloro-5-methyl-2-(1-methylethyl)-	KFZXVMNBUMVKLN-UHFFFAOYSA-N
DB19376	null	Salicylanilide	87-17-2	LHP8NEY345	2-hydroxy-n-phenylbenzamide \| N-phenylsalicylamide \| Salinidol	WKEDVNSFRWHDNR-UHFFFAOYSA-N
DB19377	null	Santonin	null	1VL8J38ERO	null	null
DB19378	null	Megestrol	3562-63-8	EA6LD1M70M	17-hydroxy-6-methylpregna-4,6-diene-3,20-dione \| Chronopil	VXIMPSPISRVBPZ-NWUMPJBXSA-N
DB19379	null	Syrosingopine	84-36-6	PPG46JF0EG	Carbethoxysyringoyl methylreserpate \| Isotense \| Londomin \| Methyl 18.beta.-hydroxy-11,17.alpha.-dimethoxy-3.beta.,20.alpha.-yohimban-16.beta.-carboxylate 4-hydroxy \| Methyl carbethoxysyringoyl reserpate \| Neoreserpan \| Siringina \| Yohimban-16-carboxylic acid, 18-((4-((ethoxycarbonyl)oxy)-3,5-dimethoxybenzoyl)oxy)-11,17-dimethoxy-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)-	ZCDNRPPFBQDQHR-SSYATKPKSA-N
DB19380	null	Parethoxycaine	94-23-5	68E52E5J67	null	OWWVHQUOYSPNNE-UHFFFAOYSA-N
DB19381	null	AZACYCLONOL	115-46-8	null	Diphenyl(piperidin-4-yl)methanol	null
DB19382	null	Benzoylpas	13898-58-3	XEE879L727	4-benzamidosalicylate \| Benzamidosalicylate \| Benzoic acid, 4-(benzoylamino)-2-hydroxy-	GNZCRYWFWKFIDM-UHFFFAOYSA-N
DB19383	null	Pentapiperium	26372-86-1	E550Z24M3I	Pentapiperium cation \| Pentapiperium ion \| Piperidinium, 1,1-dimethyl-4-((3-methyl-1-oxo-2-phenylpentyl)oxy)-	WSWDKMFWJOALEW-UHFFFAOYSA-N
DB19384	null	Propionate ion	72-03-7	AKW5EM890C	Propanoate ion \| Propanoic acid anion \| Propanoic acid, ion(1-) \| Propionate	XBDQKXXYIPTUBI-UHFFFAOYSA-M
DB19385	null	Asm-024 cation	1609534-88-4	7N7MB1SWWJ	1,1-diethyl-4-phenylhomopiperazinium \| 1h-1,4-diazepinium, 1,1-diethylhexahydro-4-phenyl-	DAPFMGRCDFSUSN-UHFFFAOYSA-N
DB19386	null	Miramistin ion	91481-38-8	62S6VPY15U	Benzenemethanaminium, n,n-dimethyl-n-(3-((1-oxotetradecyl)amino)propyl)- \| Miramistin	YEAYHNRJRKXWNV-UHFFFAOYSA-O
DB19387	null	Acetomenaphthone	573-20-6	DWG8UZD9HT	1,4-diacetoxy-2-methylnaphthalene \| 2-methyl-1,4-naphthylene diacetate \| Acetomenaphthone \| Acetomenaphtone \| Menadiol diacetate \| Vitamin K4	RYWSYCQQUDFMAU-UHFFFAOYSA-N
DB19389	null	ION356	null	null	null	null
DB19390	null	BA1301	null	null	null	null
DB19397	null	AZD8630	null	null	null	null
DB19409	null	Fosigotifator	2415715-84-1	3FQ7XKK8AY	null	IURMHIZNAHLQRX-ANYOXOOPSA-N
DB19410	null	Evalstotug	2460399-39-5	ZT62XSC86F	Gamma1 heavy chain (1-447) [VH (Homo sapiens IGHV3-3002 (91.8%) -(IGHD) -IGHJ401 (100%), CDR-IMGT [8.8.11] (26-33.51-58.97-107)) (1-118) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, CH3 D12, L14 (CH1 R120 (215) (119-216), hinge 1-15 (217-231), CH2 \| Immunoglobulin G1 [de-448-lysine], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal BA3071 γ1-chain), disulfide with human monoclonal BA3071 κ-chain, dimer \| Immunoglobulin G1-kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], monoclonal antibody	null
DB19411	null	Coramitug	2626841-92-5	1D57NC901Z	Coramitug \| Immunoglobulin G1, anti-(human transthyretin) (human-Mus musculus monoclonal PRX004 γ1-chain), disulfide with human-Mus musculus monoclonal PRX004 κ-chain, dimer	null
DB19412	null	Xempritolimod	2639319-18-7	H38O6N0BDX	KMRC011, a flagellin-derived radiation countermeasure \| Xempritolimod	null

DB19294

null

Japanese Encephalitis Virus Vaccine Inactivated

null

2V2JJ0S00T

JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED | JE-VAX

null

DB19295

null

Platelet Rich Plasma

null

ZW1U5HYZ1A

AUTOLOGOUS CONDITIONED PLASMA | AUTOLOGOUS PLATELET RICH PLASMA | PLATELET RICH PLASMA HUMAN | PLATELET-RICH PLASMA, AUTOLOGOUS | PRP

null

DB19296

null

Linopristin

325965-23-9

312V80FR4J

Nxl-103 component rpr-202868

NVGNYGXBILPHOS-VXNAYKIUSA-N

DB19297

null

Human placenta hydrolysate

null

24L835P10X

Laennec

null

DB19298

null

7MW3711

null

DB19299

null

Interleukin-12 human recombinant

null

02FXP10O2U

Human interleukin 12 recombinant | Human interleukin-12 recombinant | Interleukin-12 human recombinant | Recombinant human interleukin 12

null

DB19300

null

Crisugabalin

2209104-84-5

Q3MK7E8686

Crisugabalin

WCEFMBSFXJUREW-LIJGXYGRSA-N

DB19301

null

Solrikitug

2768721-24-8

WYT4WRY5YF

Immunoglobulin G1-kappa, anti-[Homo sapiens CRLF2 (cytokine receptor like factor 2,TSLP, thymic stromal lymphopoietin)], humanized monoclonal antibody | Solrikitug

null

DB19302

null

Recaticimab

2361290-85-7

20IE6M67UX

Immunoglobulin g1-kappa, anti-(homo sapienspcsk9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, narc1, narc-1, proproteine convertase 9, pc9)), monoclonal antibody (recaticimab) | Recaticimab

null

DB19303

null

Bemiltenase alfa

2766038-73-5

4EC84Z6PTT

null

DB19304

null

REM-422

null

c-Myb mRNA degrader REM-422 | Myb mRNA degrader REM-422 | Myb mRNA inhibitor REM-422

null

DB19305

null

JNT-517

2837993-05-0

5P44NDU6AC

(R)-3-(1-cyclopropyl-3-(2-fluoro-4-(trifluoromethoxy)benzyl)ureido)piperidine-1-carboxamide | 1-Piperidinecarboxamide, 3-[cyclopropyl[[[[2-fluoro-4-(trifluoromethoxy)phenyl]methyl]amino]carbonyl]amino]-, (3R)-

FNRHWODWSBDOOY-CYBMUJFWSA-N

DB19306

null

XK-469 free acid

157435-10-4

A9M6WCT45L

PROPANOIC ACID, 2-(4-((7-CHLORO-2-QUINOXALINYL)OXY)PHENOXY)-, (±)- | XK 469 free acid | XK469 free acid

NUQZXROIVGBRGR-UHFFFAOYSA-N

DB19307

null

Human anti-il-6 monoclonal antibody (pf-04236921)

1822383-06-1

2NHW9AKY9C

HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY (PF-04236921)

null

DB19308

null

Coptisine

3486-66-6

0GCL71VN14

6,7-dihydrobis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium | 7,8,13,13a-tetradehydro-2,3:9,10-bismethylenedioxyberbinium | Alkaloid a, from coptis groenlandica | Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)- | Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro- | Bis(methylenedioxy)protoberberine | Coptisin

XYHOBCMEDLZUMP-UHFFFAOYSA-N

DB19309

null

IMM-0306

null

HFR7WU5YK7

IMM0306 (BISPECIFIC ANTIBODY-TRAP SELECTIVELY TARGETING CD47 AND CD20)

null

DB19310

null

Rhodamine 123 free base

104114-27-4

05D072FS97

Benzoic acid, 2-(6-amino-3-imino-3h-xanthen-9-yl)-, methyl ester

FCGVBHISQBBIQF-UHFFFAOYSA-N

DB19311

null

Farglitazar

274687-78-4

3433GY7132

L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)- | N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE

ZZCHHVUQYRMYLW-HKBQPEDESA-N

DB19312

null

Sipoglitazar

342026-92-0

40O898CJZB

3-(3-ethoxy-1-(4-((2-phenyl-1,3-thiazol-4-yl)methoxy)benzyl)-1h-pyrazol-4-yl)propanoic acid

SRFCAWATPLCLMG-UHFFFAOYSA-N

DB19313

null

Salvianolic acid B

121521-90-2

C1GQ844199

(2s,3s)-4-((1e)-3-((1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propen-1-yl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylic acid 3-((1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl) ester | Dan shen suan b | Danfensuan b | Lithospermic acid b | Salvianolic acid b (constituent of chinese salvia)

SNKFFCBZYFGCQN-VWUOOIFGSA-N

DB19314

null

Nemonapride

75272-39-8

Q88T5P3444

(+/-)-cis-n-(1-benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide | Benzamide, 5-chloro-2-methoxy-4-(methylamino)-n-(2-methyl-1- (phenylmethyl)-3-pyrrolidinyl)-, cis-(+/-)- | Emilace | Emonapride

KRVOJOCLBAAKSJ-RDTXWAMCSA-N

DB19315

null

Zelasudil

2365193-22-0

EEF2SY7GG2

Zelasudil

null

DB19316

null

Budoprutug

2720478-38-4

E4ET672BAP

Budoprutug

null

DB19317

null

KT-A261

null

DB19318

null

Pegtarazimod

2056232-82-5

7AUD376O4W

Pa-dpeg24 | Pegtarazimod

null

DB19319

null

Enisoprost

81026-63-3

J85F4K48Q1

(+/-)-methyl (z)-7-((1r,2r,3r)-3-hydroxy-2-((e)-(4rs)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentyl)-4-heptenoate | Enisoprost | Prosta-4,13-dien-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (4z,11.alpha.,13e)-(+/-)-

CIBHDGPIOICRGX-ZQCHCGQNSA-N

DB19320

null

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (propiolactone inactivated)

null

DB19321

null

Influenza A virus A/Sydney/1304/2022 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)

null

DB19322

null

Influenza A virus A/Massachusetts/18/2022 (H3N2) recombinant hemagglutinin antigen

null

DB19323

null

Influenza A virus A/Thailand/8/2022 IVR-237 (H3N2) antigen (formaldehyde inactivated)

null

DB19324

null

Influenza A virus A/Thailand/8/2022 IVR-237 antigen (UV, formaldehyde inactivated)

null

DB19325

null

Sofpironium

1628251-49-9

00Y6A5AJU6

Pyrrolidinium, 3-(((2r)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy)-1-(2-ethoxy-2-oxoethyl)-1-methyl-, (3r)- | Sofpironium cation | Sofpironium ion

SEVCTUCCZYBJER-BSJAROSPSA-N

DB19326

null

Sabestomig

2648346-74-9

X79QP2R2CZ

Immunoglobulin G1 [239-phenylalanine,240-glutamic acid,336-serine,354-cysteine,371-serine,373-alanine,412-valine], bispecific, anti-(human programmed cell death protein 1) (human-Mus musculus clone LO115 γ1-chain) disulfide with human-Mus musculus clone | Immunoglobulin G1-kappa/lambda, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD1, PD-1, CD279) and HAVCR2 (hepatitis A virus cellular receptor 2, T cell immunoglobulin and mucin domains family member 3, TIM3, TIM-3, TIMD3, CD366)], humanized and Ho

null

DB19327

null

Vilastobart

2760549-50-4

8FUE2D4G82

gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV1-69*08 (84.7%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT[8.8.12] (26-33.51-58.97-108)) (1-119) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, D12, L14, G1v7 CH2 D3, E117 (CH1 K120 (216) (120-217), hinge 1- | immunoglobulin G1-fused prodomain kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], humanized monoclonal antibody

null

DB19328

null

Bleximenib

2654081-35-1

DCN5WEN78T

Benzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)- | N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamide

PDUGAXSIWNMIBQ-HHHXNRCGSA-N

DB19329

null

Azelaprag

2049980-18-7

4B8REJ8ZGY

2-pyrimidineethanesulfonamide, n-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-.alpha.,.beta.,5-trimethyl-, (.alpha.s,.beta.r)-

DOMQFIFVDIAOOT-ROUUACIJSA-N

DB19330

null

Tomligisiran

2202789-48-6

35S90A5FLO

RNA, ((1'-DE(6-AMINO-9H-PURIN-9-YL))DA-(5'->5')-CM-GM-CM-UM-GM-UM-AM-GM-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)A-UM-AM-AM-AM-UM-UM-GM-GM-UM-AM-(3'->3')-SP-(1'-DE(6-AMINO-9H-PURIN-9-YL))DA), 3'-(O-(CIS-4-((3S,8S)-17-((2-(ACETYLAMI

null

DB19331

null

Daplusiran

2202783-35-3

HP2ZTB8W0F

RNA, (AM-SP-(2'-DEOXY-2'-FLUORO)G-SP-AM-SP-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)A-UM-(2'-DEOXY-2'-FLUORO)U-GM-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)A-GM-(2'-DEOXY-2'-FLUORO)A-AM-(2'-DEOXY-2'-FLUORO)G-UM-(2'-DEOXY-2'-FLUORO)C-CM-AM-SP-CM),

null

DB19332

null

Zifibancimig

2517939-46-5

4UIR9KL62T

Immunoglobulin G1 Fab fragment, bispecific, anti-(human vascular endothelial growth factor A and angiopoietin 2) (human monoclonal RO7250284 γ1-chain), disulfide with human monoclonal RO7250284 κ-chain | mmunoglobulin Fab G1-kappa, anti-[Homo sapiens ANGPT2 (angiopoietin 2, Ang2)] and anti-[Homo sapiens VEGFA (vascular endothelial growth factor A, VEGF-A, VEGF), monoclonal antibody, bispecific, biparatope monovalent

null

DB19333

null

Abiprubart

2765071-95-0

TIN30KQI3W

Gamma4 heavy chain humanized (1-441) [VH (Homo sapiens IGHV1-3*01 (83.7%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [8.8.7] (26-33.51-58.97-103)) (1-114)-Homo sapiens IGHG4*01, nG4m(a) CH2 L92, G4v5 h P10 (CH1 (115-212), hinge 1-12 S10>P (222) (213-224), CH2 L | Immunoglobulin G4 [222-proline], anti-(human CD40 antigen) (human-Mus musculus monoclonal KPL-404 γ4-chain), disulfide with human-Mus musculus monoclonal KPL-404 κ-chain, dimer | Immunoglobulin G4-kappa, anti-[Homo sapiens CD40 (TNFRSF5, tumor necrosis factor receptor (TNFR) superfamily member 5, p50)], humanized monoclonal antibody

null

DB19334

null

Nelistotug

2645437-82-5

7MCC43O1YB

Gamma1 heavy chain Homo sapiens (1-452) [VH(Homo sapiens IGHV1-69*01 (95.9%) -(IGHD)-IGHJ1*01 (90.9%) L123>T (117), CDR-IMGT [8.8.15](26-33.51-58.97-111)) (1-122) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (219) (123-220), hi | Immunoglobulin G1, anti-(human CD96 antigen) (human monoclonal GSK6097608 γ1-chain), disulfide with human monoclonal GSK6097608 κ-chain, dimer | Nelistotug (immunoglobulin G1-kappa, anti-[Homo sapiens CD96 (T cell activation increased late expression, TACTILE, T-cell surface protein tactile)], Homo sapiens monoclonal antibody)

null

DB19335

null

Peginterferon Alfacon-2

1848968-91-1

45EW5LFT2J

Interferon .alpha.1 (synthetic), n-terminal 20-kilodalton pegylated

null

DB19336

null

Zelquistinel

2151842-64-5

387WYR6N95

tert-butyl (4S)-2-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-3-oxo-2,5-diazaspiro[3.4]octane-5-carboxylate

ABAPCYNTEPGBNJ-FTGAXOIBSA-N

DB19337

null

Nesvategrast

1621332-91-9

49958O183Z

(s)-3-(6-(difluoromethoxy)pyridin-3-yl)-3-(oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoate | 3-Pyridinepropanoic acid, 6-(difluoromethoxy)-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-, (βS)- | βS)-6-(Difluoromethoxy)-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-3-pyridinepropanoic acid

IGUVQCZYMKVWFL-SFHVURJKSA-N

DB19338

null

Tebapivat

null

ORG4KGP5ZS

6-[(6-aminopyridin-2-yl)methyl]-4-methyl-2-[(1H-pyrazol-3-yl)methyl]-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one

DIUOELXIXSCFCR-UHFFFAOYSA-N

DB19339

null

Maridebart Cafraglutide

2760218-55-9

Z24U3U73HN

gamma1 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV3-33*01 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v64 CH2 C36, G1v54-30 CH2 C83, G8 | Immunoglobulin G1, anti-(glucose-dependent insulinotropic polypeptide receptor) [275-cysteine,295-cysteine,300-glycine,305-cysteine] (human γ1-chain), disulfide with human κ-chain, dimer, 275,275′-bis(thioether) with 7-37-glucagon-like peptide I [8-(

null

DB19340

null

Tabirafusp tedromer

2412170-98-8

8ES4CE6CXN

1-[1,1,1-tris({3-[2-(2,2,2-tris{[(2-{α-(bromo / ethoxy / hydro / hydroxy)poly[1-(10,10-dimethyl-6-oxido-6-oxo-2,5,7-trioxa-10-aza-6λ5-phosphaundecan-10-ium-1-oyl)-1-methylethane-1,2-diyl]-ω-yl}-2-methylpropanoyl)oxy]methyl}ethoxy)acetamido]propanamido | 3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6 | Tedromer

GRHIAJGAQUTOSV-UHFFFAOYSA-N

DB19341

null

Englumafusp alfa

2417199-08-5

U4T9GD9GR9

71-248-4-1BB ligand (human precursor) fusion protein with peptide linker (GGGGS)2 fusion protein with 71-248-4-1BB ligand (human precursor) peptide linker (GGGGS)2 fusion protein with human κ-chain C region fusion protein with immunoglobulin G1 [497-ala | Ensomafusp alfa | humanized immunoglobulin G1-kappa anti-(human B-lymphocyte antigen CD19) modified heterodimer where the heavy and light chain variable regions of one arm have been substituted by three subunits of human 4- 1BB ligand (tumor necrosis factor ligand superfa

null

DB19342

null

Streptococcus pneumoniae type 9N capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

XI7GQF2NHD

null

DB19343

null

Streptococcus pneumoniae type 15A capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19344

null

Streptococcus pneumoniae type deOAc15B capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19345

null

Streptococcus pneumoniae type 16F capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19346

null

Streptococcus pneumoniae type 17F capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19347

null

Streptococcus pneumoniae type 20A capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19348

null

Streptococcus pneumoniae type 23A capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19349

null

Streptococcus pneumoniae type 23B capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19350

null

Streptococcus pneumoniae type 24F capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19351

null

Streptococcus pneumoniae type 31 capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19352

null

Streptococcus pneumoniae type 35B capsular polysaccharide diphtheria CRM197 protein conjugate antigen

null

DB19353

null

Benzgalantamine

224169-27-1

XOI2Q0ZF7G

6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, benzoate (ester), (4as,6r,8as)- | Galantamine benzoate | Memogain

JKVNJTYHRABHIY-WXVUKLJWSA-N

DB19354

null

Hydrastine

118-08-1

8890V3217X

(s)-6,7-dimethoxy-3-(r)-(6-methyl-5,6,7,8-tetrahydro-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)isobenzofuran-1(3h)-one | Hydrastine (constituent of goldenseal) | Phthalide (s)-6,7-dimethoxy-3-(r)-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-

JZUTXVTYJDCMDU-MOPGFXCFSA-N

DB19355

null

Chlorindanol

145-94-8

7902N03BH0

1h-inden-4-ol, 7-chloro-2,3-dihydro- | 7-chloro-4-indanol | Clorindanol

ATAJVFBUUIBIEO-UHFFFAOYSA-N

DB19356

null

Carboprost

35700-23-3

7B5032XT6O

(15s)-15-methyl-pgf2.alpha. | (15s)-15-methylprostaglandin f(sub 2.alpha.) | (15s)-15-methylprostaglandin f2.alpha. | (5z,9.alpha.,11.alpha.,13e,15s)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid | (e,z)-(1r,2r,3r,5s)-7-(3,5-dihydroxy-2-((3s)-(3-hydroxy-3-methyl-1-octenyl))cyclopentyl)-5-heptenoic acid | 15-methyl-pgf2.alpha. | 15-methylprostaglandin f2.alpha. | 15-methylprostaglandin f2beta, (15s)- | 15(S)-15-Methyl Prostaglandin F2α | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5z,9.alpha.,11.alpha.,13e,15s)-

DLJKPYFALUEJCK-IIELGFQLSA-N

DB19357

null

Salicin

138-52-3

4649620TBZ

NGFMICBWJRZIBI-UJPOAAIJSA-N

DB19358

null

Chlorisondamine

7701-62-4

JD3M24F66I

1h-isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2- (trimethylammonio)ethyl)- | Chlorisondamine cation | Chlorisondamine ion | Isoindolinium, 4,5,6,7-tetrachloro-2-methyl-2-(2- (trimethylammonio)ethyl)-

IXWDUZLHWJKVPX-UHFFFAOYSA-N

DB19359

null

Hydrastinine

6592-85-4

V1I0L48X6E

1-hydroxy-6,7-methylenedioxy-2-methyl-1,2,3,4-tetrahydroisoquinoline | 1,3-dioxolo(4,5-g)isoquinolin-5-ol | 5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-ol

YOJQZPVUNUQTDF-UHFFFAOYSA-N

DB19360

null

Latanoprost acid

41639-83-2

EJ85341990

13,14-dihydro-17-phenyl trinor pgf2.alpha. | 13,14-dihydro-17-phenyl-18,19,20-trinor-pgf2.alpha. | 5-heptenoic acid, 7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((3r)-3-hydroxy-5-phenylpentyl)cyclopentyl)-, (5z)- | Latanoprost related compound e

HNPFPERDNWXAGS-NFVOFSAMSA-N

DB19361

null

Aurothioglycanide

16925-51-2

2A9D34A16M

ODENGJOFMCVWCT-UHFFFAOYSA-M

DB19362

null

Glyceryl monocaprylate

26402-26-6

TM2TZD4G4A

null

DB19363

null

Mephenesin carbamate

533-06-2

PAD6SXB23N

3-(2-methylphenoxy)-1,2-propanediol 1-carbamate

KRPAJLYSLFNDOA-UHFFFAOYSA-N

DB19364

null

Azaribine

2169-64-4

K1U80DO9EB

1,2,4-triazine-3,5(2h,4h)-dione, 2-(2,3,5-tri-o-acetyl-.beta.-d-ribofuranosyl)- | 2-.beta.-d-ribofuranosyl-as-triazine-3,5(2h,4h)-dione 2',3',5'-triacetate | 6-azauridine 2',3',5'-triacetate | Triazure

QQOBRRFOVWGIMD-OJAKKHQRSA-N

DB19365

null

Aminometradine

642-44-4

PPM8SX5Q3V

1-allyl-6-amino-3-ethyluracil

NGXUUAFYUCOICP-UHFFFAOYSA-N

DB19367

null

Tiphenamil

82-99-5

GX4D5197DT

Benzeneethanethioic acid, .alpha.-phenyl-, s-(2-(diethylamino)ethyl) ester | Benzeneethanethioic acid, a-phenyl-, s-(2-(diethylamino)ethyl) ester | Thiphenamil | Tifenamil

WHLUQAYNVOGZST-UHFFFAOYSA-N

DB19368

null

Amisometradine

550-28-7

30973N61ZF

2,4(1h,3h)-pyrimidinedione, 6-amino-3-methyl-1-(2-methyl-2-propenyl)- | 6-amino-3-methyl-1-(2-methylallyl)-2,4(1h,3h)-pyrimidinedione

FXNYSZHYMGWWEZ-UHFFFAOYSA-N

DB19369

null

Mitomycin A

4055-39-4

87TMG6FJHV

6-methoxy analog of mitomycin c | Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methyl-, (1as,8s,8ar,8bs)-

HYFMSAFINFJTFH-NGSRAFSJSA-N

DB19370

null

Methylhexaneamine

105-41-9

X49C572YQO

YAHRDLICUYEDAU-UHFFFAOYSA-N

DB19371

null

NITHIAMIDE

140-40-9

9CBM60191Z

2-acetamido-5-nitrothiazole | Acetamide, n-(5-nitro-2-thiazolyl)- | Acinitrazole | Aminitrozole | N-(5-nitro-2-thiazolyl)acetamide

UJRRDDHEMZLWFI-UHFFFAOYSA-N

DB19372

null

Zoxazolamine

61-80-3

9DOW362Q29

YGCODSQDUUUKIV-UHFFFAOYSA-N

DB19373

null

Phenaglycodol

79-93-6

LMQ31KU50K

HTYIXCKSEQQCJO-UHFFFAOYSA-N

DB19374

null

OCTODRINE

543-82-8

3GQ9E911BI

1,5-dimethylhexylamine | 6-methyl-2-heptylamine | Hexylamine, 1,5-dimethyl-

QNIVIMYXGGFTAK-UHFFFAOYSA-N

DB19375

null

Chlorothymol

89-68-9

LJ25TI0CVT

4-chlor-2-isopropyl-5-methylphenol | 4-chloro-5-methyl-2-(1-methylethyl)phenol | 4-chlorothymol | 6-chlorothymol | Phenol, 4-chloro-5-methyl-2-(1-methylethyl)-

KFZXVMNBUMVKLN-UHFFFAOYSA-N

DB19376

null

Salicylanilide

87-17-2

LHP8NEY345

2-hydroxy-n-phenylbenzamide | N-phenylsalicylamide | Salinidol

WKEDVNSFRWHDNR-UHFFFAOYSA-N

DB19377

null

Santonin

null

1VL8J38ERO

null

DB19378

null

Megestrol

3562-63-8

EA6LD1M70M

17-hydroxy-6-methylpregna-4,6-diene-3,20-dione | Chronopil

VXIMPSPISRVBPZ-NWUMPJBXSA-N

DB19379

null

Syrosingopine

84-36-6

PPG46JF0EG

Carbethoxysyringoyl methylreserpate | Isotense | Londomin | Methyl 18.beta.-hydroxy-11,17.alpha.-dimethoxy-3.beta.,20.alpha.-yohimban-16.beta.-carboxylate 4-hydroxy | Methyl carbethoxysyringoyl reserpate | Neoreserpan | Siringina | Yohimban-16-carboxylic acid, 18-((4-((ethoxycarbonyl)oxy)-3,5-dimethoxybenzoyl)oxy)-11,17-dimethoxy-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)-

ZCDNRPPFBQDQHR-SSYATKPKSA-N

DB19380

null

Parethoxycaine

94-23-5

68E52E5J67

null

OWWVHQUOYSPNNE-UHFFFAOYSA-N

DB19381

null

AZACYCLONOL

115-46-8

null

Diphenyl(piperidin-4-yl)methanol

null

DB19382

null

Benzoylpas

13898-58-3

XEE879L727

4-benzamidosalicylate | Benzamidosalicylate | Benzoic acid, 4-(benzoylamino)-2-hydroxy-

GNZCRYWFWKFIDM-UHFFFAOYSA-N

DB19383

null

Pentapiperium

26372-86-1

E550Z24M3I

Pentapiperium cation | Pentapiperium ion | Piperidinium, 1,1-dimethyl-4-((3-methyl-1-oxo-2-phenylpentyl)oxy)-

WSWDKMFWJOALEW-UHFFFAOYSA-N

DB19384

null

Propionate ion

72-03-7

AKW5EM890C

Propanoate ion | Propanoic acid anion | Propanoic acid, ion(1-) | Propionate

XBDQKXXYIPTUBI-UHFFFAOYSA-M

DB19385

null

Asm-024 cation

1609534-88-4

7N7MB1SWWJ

1,1-diethyl-4-phenylhomopiperazinium | 1h-1,4-diazepinium, 1,1-diethylhexahydro-4-phenyl-

DAPFMGRCDFSUSN-UHFFFAOYSA-N

DB19386

null

Miramistin ion

91481-38-8

62S6VPY15U

Benzenemethanaminium, n,n-dimethyl-n-(3-((1-oxotetradecyl)amino)propyl)- | Miramistin

YEAYHNRJRKXWNV-UHFFFAOYSA-O

DB19387

null

Acetomenaphthone

573-20-6

DWG8UZD9HT

RYWSYCQQUDFMAU-UHFFFAOYSA-N

DB19389

null

ION356

null

DB19390

null

BA1301

null

DB19397

null

AZD8630

null

DB19409

null

Fosigotifator

2415715-84-1

3FQ7XKK8AY

null

IURMHIZNAHLQRX-ANYOXOOPSA-N

DB19410

null

Evalstotug

2460399-39-5

ZT62XSC86F

Gamma1 heavy chain (1-447) [VH (Homo sapiens IGHV3-30*02 (91.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.11] (26-33.51-58.97-107)) (1-118) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, CH3 D12, L14 (CH1 R120 (215) (119-216), hinge 1-15 (217-231), CH2 | Immunoglobulin G1 [de-448-lysine], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal BA3071 γ1-chain), disulfide with human monoclonal BA3071 κ-chain, dimer | Immunoglobulin G1-kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], monoclonal antibody

null

DB19411

null

Coramitug

2626841-92-5

1D57NC901Z

Coramitug | Immunoglobulin G1, anti-(human transthyretin) (human-Mus musculus monoclonal PRX004 γ1-chain), disulfide with human-Mus musculus monoclonal PRX004 κ-chain, dimer

null

DB19412

null

Xempritolimod

2639319-18-7

H38O6N0BDX

KMRC011, a flagellin-derived radiation countermeasure | Xempritolimod

null